BioXcel Therapeutics Inc (BTAI) Stock Price, Quote, News & History

BTAINASDAQ

Trade with Public

$0.0422

-0.0317-42.9%

Last update: Sep 4, 7:59 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

Volume / Avg.

0 / 6.88M

Day Range

- - -

52 Wk Range

0.07 - 3.19

Market Cap

$1.32M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent BioXcel Therapeutics Inc News

Dow Falls Over 100 Points; US Economy Adds 162,000 Jobs In August

U.S. stocks mixed as Dow and S&P fell despite strong August job gains; tech rose, energy slid, and oil, gold and silver declined.

Avi Kapoor

Why Samsara Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Samsara jumped 14.8% premarket after Q2 results beat estimates; several stocks surged, while DSS plunged 36.4% on a proposed offering.

Avi Kapoor

Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket

Snowflake shares surged 24% after Q2 revenue and earnings beat estimates; other premarket gainers and losers made notable moves.

Avi Kapoor

Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75 Billion, BioXcel Bankruptcy

Major M&A deals this week include: The Descartes Systems buys Tai, KKR nabs Ci FLAVORS, Skimmer Acquires Pool Builder Geek and Poologics.

Caroline Ryan

BioXcel Stock Plunges: Chapter 11 Filing Triggers Teva Stalking Horse Bid

BioXcel Chapter 11 sends BTAI shares sharply lower as Teva becomes the stalking horse bidder for IGALMI and BXCL501 assets.

Akanksha Bakshi

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

Volume / Avg.

0 / 6.88M

Day Range

- - -

52 Wk Range

0.07 - 3.19

Market Cap

$1.32M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

BTAI

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

BTAI

FAQ

How do I buy BioXcel Therapeutics Inc (BTAI) stock?

You can purchase shares of BioXcel Therapeutics Inc (NASDAQ:BTAI) through any online brokerage.

View our list of the best stock brokerages

Who are BioXcel Therapeutics Inc (BTAI) competitors?

There are no as such competitors for BioXcel Therapeutics Inc.

What is the forecast, or price target, for BioXcel Therapeutics Inc (BTAI) stock?

BioXcel Therapeutics Inc has a consensus price target of $32.13.

What is the current price for BioXcel Therapeutics Inc (BTAI)?

The stock price for BioXcel Therapeutics Inc (NASDAQ: BTAI) is $0.0422 last updated September 4, 2026 at 7:59 PM EDT.

Does BioXcel Therapeutics Inc (BTAI) pay a dividend?

There are no upcoming dividends for BioXcel Therapeutics Inc.

When is BioXcel Therapeutics Inc (NASDAQ:BTAI) reporting earnings?

BioXcel Therapeutics Inc does not have any upcoming earnings scheduled.

Is BioXcel Therapeutics Inc (BTAI) going to split?

There is no upcoming split for BioXcel Therapeutics Inc.